A citation-based method for searching scientific literature

M Alejandra Tortorici, Martina Beltramello, Florian A Lempp, Dora Pinto, Ha V Dang, Laura E Rosen, Matthew McCallum, John Bowen, Andrea Minola, Stefano Jaconi, Fabrizia Zatta, Anna De Marco, Barbara Guarino, Siro Bianchi, Elvin J Lauron, Heather Tucker, Jiayi Zhou, Alessia Peter, Colin Havenar-Daughton, Jason A Wojcechowskyj, James Brett Case, Rita E Chen, Hannah Kaiser, Martin Montiel-Ruiz, Marcel Meury, Nadine Czudnochowski, Roberto Spreafico, Josh Dillen, Cindy Ng, Nicole Sprugasci, Katja Culap, Fabio Benigni, Rana Abdelnabi, Shi-Yan Caroline Foo, Michael A Schmid, Elisabetta Cameroni, Agostino Riva, Arianna Gabrieli, Massimo Galli, Matteo S Pizzuto, Johan Neyts, Michael S Diamond, Herbert W Virgin, Gyorgy Snell, Davide Corti, Katja Fink, David Veesler. Science 2020
Times Cited: 292



Rui Shi, Chao Shan, Xiaomin Duan, Zhihai Chen, Peipei Liu, Jinwen Song, Tao Song, Xiaoshan Bi, Chao Han, Lianao Wu, Ge Gao, Xue Hu, Yanan Zhang, Zhou Tong, Weijin Huang, William Jun Liu, Guizhen Wu, Bo Zhang, Lan Wang, Jianxun Qi, Hui Feng, Fu-Sheng Wang, Qihui Wang, George Fu Gao, Zhiming Yuan, Jinghua Yan. Nature 2020
Times Cited: 737




List of shared articles



Times cited

SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment.
Dapeng Li, Gregory D Sempowski, Kevin O Saunders, Priyamvada Acharya, Barton F Haynes. Annu Rev Med 2022
19

An ultrapotent pan-β-coronavirus lineage B (β-CoV-B) neutralizing antibody locks the receptor-binding domain in closed conformation by targeting its conserved epitope.
Zezhong Liu, Wei Xu, Zhenguo Chen, Wangjun Fu, Wuqiang Zhan, Yidan Gao, Jie Zhou, Yunjiao Zhou, Jianbo Wu, Qian Wang,[...]. Protein Cell 2022
4

Unravelling the molecular interactions between the SARS-CoV-2 RBD spike protein and various specific monoclonal antibodies.
Didac Martí, Marc Alsina, Carlos Alemán, Oscar Bertran, Pau Turon, Juan Torras. Biochimie 2022
2

Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain.
Katherine G Nabel, Sarah A Clark, Sundaresh Shankar, Junhua Pan, Lars E Clark, Pan Yang, Adrian Coscia, Lindsay G A McKay, Haley H Varnum, Vesna Brusic,[...]. Science 2022
18

Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection.
Yu-Chyi Hwang, Ruei-Min Lu, Shih-Chieh Su, Pao-Yin Chiang, Shih-Han Ko, Feng-Yi Ke, Kang-Hao Liang, Tzung-Yang Hsieh, Han-Chung Wu. J Biomed Sci 2022
12

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies.
Yunlong Cao, Jing Wang, Fanchong Jian, Tianhe Xiao, Weiliang Song, Ayijiang Yisimayi, Weijin Huang, Qianqian Li, Peng Wang, Ran An,[...]. Nature 2022
198

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.
Elisabetta Cameroni, John E Bowen, Laura E Rosen, Christian Saliba, Samantha K Zepeda, Katja Culap, Dora Pinto, Laura A VanBlargan, Anna De Marco, Julia di Iulio,[...]. Nature 2022
195

Neutralizing monoclonal antibodies against highly pathogenic coronaviruses.
Rong Xiang, Yang Wang, Lili Wang, Xiaoqian Deng, Shanshan Huo, Shibo Jiang, Fei Yu. Curr Opin Virol 2022
0

An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies.
Laura A VanBlargan, John M Errico, Peter J Halfmann, Seth J Zost, James E Crowe, Lisa A Purcell, Yoshihiro Kawaoka, Davide Corti, Daved H Fremont, Michael S Diamond. Nat Med 2022
105

A pandemic-enabled comparison of discovery platforms demonstrates a naïve antibody library can match the best immune-sourced antibodies.
Fortunato Ferrara, M Frank Erasmus, Sara D'Angelo, Camila Leal-Lopes, André A Teixeira, Alok Choudhary, William Honnen, David Calianese, Deli Huang, Linghan Peng,[...]. Nat Commun 2022
2

Parallel profiling of antigenicity alteration and immune escape of SARS-CoV-2 Omicron and other variants.
Cong Sun, Yin-Feng Kang, Yuan-Tao Liu, Xiang-Wei Kong, Hui-Qin Xu, Dan Xiong, Chu Xie, Yi-Hao Liu, Sui Peng, Guo-Kai Feng,[...]. Signal Transduct Target Ther 2022
2

An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity.
Francesco Borriello, Valentina Poli, Ellen Shrock, Roberto Spreafico, Xin Liu, Novalia Pishesha, Claire Carpenet, Janet Chou, Marco Di Gioia, Marisa E McGrath,[...]. Cell 2022
2

Cryo-EM structure of the SARS-CoV-2 Omicron spike.
Gabriele Cerutti, Yicheng Guo, Lihong Liu, Liyuan Liu, Zhening Zhang, Yang Luo, Yiming Huang, Harris H Wang, David D Ho, Zizhang Sheng,[...]. Cell Rep 2022
7

Impact of new variants on SARS-CoV-2 infectivity and neutralization: A molecular assessment of the alterations in the spike-host protein interactions.
Mary Hongying Cheng, James M Krieger, Anupam Banerjee, Yufei Xiang, Burak Kaynak, Yi Shi, Moshe Arditi, Ivet Bahar. iScience 2022
1

Computational Analysis of Mutations in the Receptor-Binding Domain of SARS-CoV-2 Spike and Their Effects on Antibody Binding.
Marine E Bozdaganyan, Konstantin V Shaitan, Mikhail P Kirpichnikov, Olga S Sokolova, Philipp S Orekhov. Viruses 2022
1



Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection.
Guidenn Sulbaran, Pauline Maisonnasse, Axelle Amen, Gregory Effantin, Delphine Guilligay, Nathalie Dereuddre-Bosquet, Judith A Burger, Meliawati Poniman, Marloes Grobben, Marlyse Buisson,[...]. Cell Rep Med 2022
0


Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529.
Tongqing Zhou, Lingshu Wang, John Misasi, Amarendra Pegu, Yi Zhang, Darcy R Harris, Adam S Olia, Chloe Adrienna Talana, Eun Sung Yang, Man Chen,[...]. Science 2022
9



Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants.
William R Strohl, Zhiqiang Ku, Zhiqiang An, Stephen F Carroll, Bruce A Keyt, Lila M Strohl. BioDrugs 2022
1

Computational approach for binding prediction of SARS-CoV-2 with neutralizing antibodies.
Daria Beshnova, Yan Fang, Mingjian Du, Yehui Sun, Fenghe Du, Jianfeng Ye, Zhijian James Chen, Bo Li. Comput Struct Biotechnol J 2022
0

Native, engineered and de novo designed ligands targeting the SARS-CoV-2 spike protein.
Carlos F S Costa, Arménio J M Barbosa, Ana Margarida G C Dias, Ana Cecília A Roque. Biotechnol Adv 2022
0

Protective neutralizing epitopes in SARS-CoV-2.
Hejun Liu, Ian A Wilson. Immunol Rev 2022
0

Ultrapotent and broad neutralization of SARS-CoV-2 variants by modular, tetravalent, bi-paratopic antibodies.
Shane Miersch, Nitin Sharma, Reza Saberianfar, Chao Chen, Francesca Caccuri, Alberto Zani, Arnaldo Caruso, James Brett Case, Michael S Diamond, Gaya K Amarasinghe,[...]. Cell Rep 2022
0

Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease.
Bennett J Davenport, Alexis Catala, Stuart M Weston, Robert M Johnson, Jeremy Ardanuy, Holly L Hammond, Carly Dillen, Matthew B Frieman, Carlos E Catalano, Thomas E Morrison. NPJ Vaccines 2022
0

Antibody-mediated neutralization of SARS-CoV-2.
Henning Gruell, Kanika Vanshylla, Timm Weber, Christopher O Barnes, Christoph Kreer, Florian Klein. Immunity 2022
0

Antibodies to combat viral infections: development strategies and progress.
Giuseppe Pantaleo, Bruno Correia, Craig Fenwick, Victor S Joo, Laurent Perez. Nat Rev Drug Discov 2022
0

Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity.
Jorge Carrillo, Nuria Izquierdo-Useros, Carlos Ávila-Nieto, Edwards Pradenas, Bonaventura Clotet, Julià Blanco. Biochem Biophys Res Commun 2021
38


Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications.
Ioannis P Trougakos, Kimon Stamatelopoulos, Evangelos Terpos, Ourania E Tsitsilonis, Evmorfia Aivalioti, Dimitrios Paraskevis, Efstathios Kastritis, George N Pavlakis, Meletios A Dimopoulos. J Biomed Sci 2021
51